Mark A. Weinberger net worth and biography

Mark Weinberger Biography and Net Worth

Director of Johnson & Johnson

Mr. Weinberger, age 62, served as the Global Chairman and Chief Executive Officer of EY (Ernst & Young) (professional services) from 2013 through June 2019, having served as Global Chairman and CEO-elect in the prior year. He was Assistant Secretary of the U.S. Treasury in the George W. Bush Administration and was appointed by President Bill Clinton to serve on the U.S. Social Security Administration Advisory Board. Mr. Weinberger serves as a Senior Advisor to Stone Canyon Industries Holdings Inc. and Teneo. He is an Executive Advisor to G100 and World 50. Mr. Weinberger also serves as a Strategic Advisor to the Board of FCLTGlobal, which focuses on long-term investing and corporate governance. Mr. Weinberger is on the Board of Directors of JUST Capital. He sits on the Board of Directors of the National Bureau of Economic Research (NBER), is a Senior Advisor to Chief Executives for Corporate Purpose (CECP). He is a member of the Boards of Trustees for Emory University, Case Western Reserve University, The Concord Coalition and The Greater Washington Partnership.

What is Mark A. Weinberger's net worth?: The estimated net worth of Mark A. Weinberger is at least $161,846.00 as of December 12th, 2024. Mr. Weinberger owns 1,000 shares of Johnson & Johnson stock worth more than $161,846 as of March 26th. This net worth estimate does not reflect any other investments that Mr. Weinberger may own. Learn More about Mark A. Weinberger's net worth.
How do I contact Mark A. Weinberger?: The corporate mailing address for Mr. Weinberger and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at investor-relations@its.jnj.com. Learn More on Mark A. Weinberger's contact information.
Has Mark A. Weinberger been buying or selling shares of Johnson & Johnson?: Mark A. Weinberger has not been actively trading shares of Johnson & Johnson during the last ninety days. Most recently, on Thursday, December 12th, Mark A. Weinberger bought 1,000 shares of Johnson & Johnson stock. The stock was acquired at an average cost of $147.22 per share, with a total value of $147,220.00. Following the completion of the transaction, the director now directly owns 1,000 shares of the company's stock, valued at $147,220. Learn More on Mark A. Weinberger's trading history.
Who are Johnson & Johnson's active insiders?: Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Chairman), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Timothy Schmid (EVP, Worldwide Chairman, MedTech), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (EVP), Jennifer Taubert (EVP), Mark Weinberger (Director), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.
Are insiders buying or selling shares of Johnson & Johnson?: During the last year, Johnson & Johnson insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $147,220.00. During the last year, insiders at the sold shares 3 times. They sold a total of 13,037 shares worth more than $2,154,035.67. The most recent insider tranaction occured on February, 25th when VP Robert J Decker sold 6,999 shares worth more than $1,160,994.12. Insiders at Johnson & Johnson own 0.2% of the company. Learn More about insider trades at Johnson & Johnson.
Information on this page was last updated on 2/25/2025.

Mark A. Weinberger Insider Trading History at Johnson & Johnson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/12/2024	Buy	1,000	$147.22	$147,220.00	1,000

Mark A. Weinberger Buying and Selling Activity at Johnson & Johnson

Johnson & Johnson Company Overview

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Today's Range

Now: $161.85

$160.64

$161.90

50 Day Range

MA: $157.70

$144.74

$167.57

2 Week Range

Now: $161.85

$140.68

$169.99

Volume

665,164 shs

Average Volume

9,087,314 shs

Market Capitalization

$390.02 billion

P/E Ratio

24.35

Dividend Yield

3.04%

Beta

0.47